Tirzepatide, marketed under the brand name Mounjaro, is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist
At the end of 40 or 42 weeks (study time varied by trial), urine albumin-to-creatinine ratio (UACR) was significantly reduced among participants assigned to tirzepatide 5, 10, or 15 mg as compared with those assigned to all pooled comparators (placebo, semaglutide, insulin degludec, and insulin glargine) with adjusted mean percent changes of 19.3% [95% CI 12.525.5%], 22.0% [95% CI 15.328.1%], and 26.3% [95% CI 20.032.0%], respectively, with a greater reduction observed in participants with a UACR 30 mg/g at baseline [96]
2800 Veterans Memorial Blvd, Suite 220A Metairie, LA 70002 Administrative Office Hours: 9:00 am 5:00 pm CST Note: Physician appointment times may vary outside of these hours, as each provider sets their own schedule
Retrieve it at the same point in your injection preparation routine
Retatrutide dosing guide Research Compounds Common questions Do I need an account
Symptoms can begin with increased heart rate, sweating, dizziness and irritability